Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-13496 (lurasidone) for treatment of bipolar I depression
jRCT2080222269Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Lurasidone with Placebo (2 arms).
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on jRCT2080222269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222269.